The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Partnering for better patient outcomes
Room:
Sat 1
Facilitator:
András Süle
Speakers:
Abstract:
Link to EAHP Statements
- Section 1 – Introductory Statement and Governance – 1.1, 1.2, 1.3, 1.4, 1.5
- Section 4 – Clinical Pharmacy services – 4.1, 4.6, 4.7
- Section 5 – Patient Safety and Quality Assurance – 5.1, 5.9
Abstract
Over the past years, the European Association for Hospital Pharmacists (EAHP) has expanded collaboration with European organisations representing other healthcare professionals and patients, and in order to foster links with these associations, this new session was created by the EAHP Board.
The aim of this new EAHP activity is to promote and showcase the collaboration between EAHP and other European healthcare organisations and to provide a platform for these associations to present an overview of their work.
In Bordeaux, the two associations that will be part of the “Partnering for better patient outcome” session are the European Federation of Crohn’s & Ulcerative Colitis Associations (EFCCA) and the European Pain Federation.
EFCCA represents 46 national Crohn’s and Ulcerative Colitis (collectively known as Inflammatory Bowel Disease or IBD) patient associations. EFCCA is an organisation of people united in our commitment to improve the life of over 10 million people living with IBD worldwide (3.4 million in Europe alone) and to give them a louder voice and more visibility.
The European Pain Federation’s (EFIC) objectives are to improve the research, education, and clinical management of pain and serve as an authoritative, science-based resource on issues related to pain and its treatment and to promote multidisciplinary and multi professional pain management and the ‘biopsychosocial’ model of pain.
The session will also have a panel discussion on the importance of patient engagement and the importance of healthcare professionals working collaboratively within the multidisciplinary teams to improve patient outcomes.
Learning objectives
After the synergy session, the participant should be able to:
- Gain an overview of the way EAHP works and interacts with other EU healthcare associations
- Learn about the work done by the European Federation of Crohn’s & Ulcerative Colitis Associations
- Learn about the work done by the European Pain Federation
- Get an insight of the discussion EAHP and other healthcare associations are having on the importance of patient engagement and the hospital pharmacists being a key stakeholder within the hospital teams
Educational need addressed
Why is it important for the profession that EAHP interacts and collaborates with other EU healthcare professionals? What work is done by the European Federation of Crohn’s? What work is done by the European Pain Federation? How does EAHP makes the voice of hospital pharmacists heard in the European Union?
Keywords
Hospital Pharmacy, collaboration, policy, patient engagement, healthcare professionals, EAHP, European Federation of Crohn’s, European Pain Federation